Correlation Engine 2.0
Clear Search sequence regions

  • Ca2 (3)
  • calcium (3)
  • calcium- channels (1)
  • cation (1)
  • clamp (2)
  • englerin (3)
  • humans (1)
  • native (2)
  • patch clamp techniques (1)
  • protein human (1)
  • purines (2)
  • research (1)
  • subunit (1)
  • trpc cation channels (2)
  • TRPC1 (10)
  • TRPC3 (2)
  • TRPC4 (5)
  • TRPC5 (9)
  • trpc5 protein, human (1)
  • TRPC6 (2)
  • TRPM2 (2)
  • TRPV4 (2)
  • Sizes of these terms reflect their relevance to your search.

    The TRPC1, TRPC4, and TRPC5 proteins form homotetrameric or heterotetrameric, calcium-permeable cation channels that are involved in various disease states. Recent research has yielded specific and potent xanthine-based TRPC1/4/5 inhibitors. Here, we investigated the possibility of xanthine-based activators of these channels. An analogue of the TRPC1/4/5 inhibitor Pico145, AM237, was synthesized and its activity was investigated using HEK cells overexpressing TRPC4, TRPC5, TRPC4-C1, TRPC5-C1, TRPC1:C4 or TRPC1:C5 channels, and in A498 cells expressing native TRPC1:C4 channels. TRPC1/4/5 channel activities were assayed by measuring intracellular concentration of Ca2+ ([Ca2+ ]i ) and by patch-clamp electrophysiology. Selectivity of AM237 was tested against TRPC3, TRPC6, TRPV4, or TRPM2 channels. AM237 potently activated TRPC5:C5 channels (EC50 15-20 nM in [Ca2+ ]i assay) and potentiated their activation by sphingosine-1-phosphate but suppressed activation evoked by (-)-englerin A (EA). In patch-clamp studies, AM237 activated TRPC5:C5 channels, with greater effect at positive voltages, but with lower efficacy than EA. Pico145 competitively inhibited AM237-induced TRPC5:C5 activation. AM237 did not activate TRPC4:C4, TRPC4-C1, TRPC5-C1, TRPC1:C5, and TRPC1:C4 channels, or native TRPC1:C4 channels in A498 cells, but potently inhibited EA-dependent activation of these channels with IC50 values ranging from 0.9 to 7 nM. AM237 (300 nM) did not activate or inhibit TRPC3, TRPC6, TRPV4, or TRPM2 channels. This study suggests the possibility for selective activation of TRPC5 channels by xanthine derivatives and supports the general principle that xanthine-based compounds can activate, potentiate, or inhibit these channels depending on subunit composition. © 2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.


    Aisling Minard, Claudia C Bauer, Eulashini Chuntharpursat-Bon, Isabelle B Pickles, David J Wright, Melanie J Ludlow, Matthew P Burnham, Stuart L Warriner, David J Beech, Katsuhiko Muraki, Robin S Bon. Potent, selective, and subunit-dependent activation of TRPC5 channels by a xanthine derivative. British journal of pharmacology. 2019 Oct;176(20):3924-3938

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 31277085

    View Full Text